251 related articles for article (PubMed ID: 29341227)
21. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective.
Wang Q; Zhang X; Wei W; Cao M
Mol Pharm; 2022 Oct; 19(10):3471-3483. PubMed ID: 35771950
[TBL] [Abstract][Full Text] [Related]
22. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
23. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics.
Tanaka K; Fukase K
Org Biomol Chem; 2008 Mar; 6(5):815-28. PubMed ID: 18292870
[TBL] [Abstract][Full Text] [Related]
24. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
25. Advances in Immuno-PET for the Detection of Cancer and Assessment of Response to Therapy.
Alauddin MM; Khawli LA
Curr Med Chem; 2021; 28(4):647-672. PubMed ID: 32003655
[TBL] [Abstract][Full Text] [Related]
26. A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.
Azad BB; Chatterjee S; Lesniak WG; Lisok A; Pullambhatla M; Bhujwalla ZM; Pomper MG; Nimmagadda S
Oncotarget; 2016 Mar; 7(11):12344-58. PubMed ID: 26848769
[TBL] [Abstract][Full Text] [Related]
27. Labeling and preliminary in vivo assessment of niobium-labeled radioactive species: A proof-of-concept study.
Radchenko V; Bouziotis P; Tsotakos T; Paravatou-Petsotas M; la Fuente Ad; Loudos G; Harris AL; Xanthopoulos S; Filosofov D; Hauser H; Eisenhut M; Ponsard B; Roesch F
Nucl Med Biol; 2016 May; 43(5):280-7. PubMed ID: 27150030
[TBL] [Abstract][Full Text] [Related]
28. State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET.
Chomet M; van Dongen GAMS; Vugts DJ
Bioconjug Chem; 2021 Jul; 32(7):1315-1330. PubMed ID: 33974403
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
30. Labeling peptides with PET radiometals: Vulcan's forge.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):209-15. PubMed ID: 18038132
[No Abstract] [Full Text] [Related]
31. PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Brouwers A; Verel I; Van Eerd J; Visser G; Steffens M; Oosterwijk E; Corstens F; Oyen W; Van Dongen G; Boerman O
Cancer Biother Radiopharm; 2004 Apr; 19(2):155-63. PubMed ID: 15186595
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of vascular targeted monoclonal antibody.
Kennel SJ; Huang Y; Zeng WB; Stuckey A; Wall J
Curr Drug Deliv; 2010 Dec; 7(5):428-35. PubMed ID: 20950267
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody-Drug Conjugates.
Azhdarinia A; Voss J; Ghosh SC; Simien JA; Hernandez Vargas S; Cui J; Yu WA; Liu Q; Carmon KS
Mol Pharm; 2018 Jun; 15(6):2448-2454. PubMed ID: 29718672
[TBL] [Abstract][Full Text] [Related]
34. Dosimetry Assessment of Injected 89Zr-Labeled Monoclonal Antibodies in Humans.
Zakaly HMH; Mostafa MYA; Zhukovsky M
Radiat Res; 2019 May; 191(5):466-474. PubMed ID: 30896281
[TBL] [Abstract][Full Text] [Related]
35. Positive progress in immunoPET--not just a coincidence.
McCabe KE; Wu AM
Cancer Biother Radiopharm; 2010 Jun; 25(3):253-61. PubMed ID: 20578830
[TBL] [Abstract][Full Text] [Related]
36. In Vitro and In Vivo Characterization of
Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126
[No Abstract] [Full Text] [Related]
37.
Zettlitz KA; Tavaré R; Tsai WK; Yamada RE; Ha NS; Collins J; van Dam RM; Timmerman JM; Wu AM
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):489-500. PubMed ID: 30456475
[TBL] [Abstract][Full Text] [Related]
38. PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.
van Dongen GA; Poot AJ; Vugts DJ
Tumour Biol; 2012 Jun; 33(3):607-15. PubMed ID: 22270450
[TBL] [Abstract][Full Text] [Related]
39. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
